Publication: Reactivation of adult-onset Still's disease after use of the COVID-19 ChAdOx1-S vaccine
dc.contributor.author | Ibáñez, Sebastián | |
dc.contributor.author | Morales Murillo, Luis | |
dc.contributor.author | Rivera Vergara, Matías de la | |
dc.contributor.author | Saldías Martínez, Roberto | |
dc.date.accessioned | 2024-06-14T14:03:44Z | |
dc.date.available | 2024-06-14T14:03:44Z | |
dc.date.issued | 2022 | |
dc.description.abstract | A woman in her 60s with a history of adult-onset Still's disease (AOSD) in remission for 14 years received the ChAdOx1-S vaccine as a booster to her initial vaccination schedule (two doses of CoronaVac vaccine 6 months apart). Two weeks later, she consulted for symptoms suggestive of AOSD reactivation. This was confirmed during hospitalisation, where renal and cardiac involvement were also observed. Despite using high-dose corticosteroids, troponin T and N-terminal pro hormone B-type natriuretic peptide (NT-proBNP) were persistently elevated. Tocilizumab was used, with which the patient achieved complete remission of her symptoms and normalised her laboratory tests. | |
dc.description.version | Versión publicada | |
dc.format.extent | 3 p. | |
dc.identifier.citation | BMJ Case Rep. 2022 Aug 26;15(8) | |
dc.identifier.doi | https://doi.org/10.1016/j.cgh.2020.10.052 | |
dc.identifier.uri | https://hdl.handle.net/11447/9095 | |
dc.language.iso | en | |
dc.rights | Atribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL) | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/cl/ | |
dc.subject | COVID-19 | |
dc.subject | Connective tissue disease | |
dc.title | Reactivation of adult-onset Still's disease after use of the COVID-19 ChAdOx1-S vaccine | |
dc.type | Article | |
dcterms.accessRights | Acceso abierto | |
dcterms.source | BMJ Case Report | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | cb424fa1-6de0-4e01-89df-dcb704e9d8f7 | |
relation.isAuthorOfPublication.latestForDiscovery | cb424fa1-6de0-4e01-89df-dcb704e9d8f7 |